Rossi Ana P, Vella John P
1 Division of Nephrology and Transplantation, Maine Medical Center, Portland, ME.
Transplantation. 2016 Mar;100(3):506-14. doi: 10.1097/TP.0000000000000916.
After transplantation of nonrenal solid organs, an acute decline in kidney function develops in the majority of patients. In addition, a significant number of nonrenal solid organ transplant recipients develop chronic kidney disease, and some develop end-stage renal disease, requiring renal replacement therapy. The incidence varies depending on the transplanted organ. Acute kidney injury after nonrenal solid organ transplantation is associated with prolonged length of stay, cost, increased risk of death, de novo chronic kidney disease, and end-stage renal disease. This overview focuses on the risk factors for posttransplant acute kidney injury after liver and heart transplantation, integrating discussion of proteinuria and chronic kidney disease with emphasis on pathogenesis, histopathology, and management including the use of mechanistic target of rapamycin inhibition and costimulatory blockade.
在非肾实质性器官移植后,大多数患者会出现肾功能急性下降。此外,相当数量的非肾实质性器官移植受者会发展为慢性肾脏病,部分患者会发展为终末期肾病,需要进行肾脏替代治疗。发病率因移植器官的不同而有所差异。非肾实质性器官移植后的急性肾损伤与住院时间延长、费用增加、死亡风险升高、新发慢性肾脏病以及终末期肾病相关。本综述重点关注肝移植和心脏移植后移植后急性肾损伤的危险因素,结合蛋白尿和慢性肾脏病的讨论,重点阐述发病机制、组织病理学以及管理,包括雷帕霉素作用靶点抑制和共刺激阻断的应用。